ESR1 and breast cancer: Some studies have shown that resistance occurs via up-regulation of pro-survival members of the BCL-2 family, including BCL-2 and MCL-1, although BCL-2 is commonly associated with ER positivity and better prognosis in breast cancer, being a favorable prognostic marker [148,149].